Use of Pembrolizumab in Non-Small Cell Lung Cancer (NSCLC)
| Name | Uganda Cancer Institute |
|---|---|
| Activity Title | Use of Pembrolizumab in Non-Small Cell Lung Cancer (NSCLC) |
| Details | CME session providing updates in use of monoclonal antibodies in Lung Cancer |
| Competence | General Medicine |
| Start Date | 14-02-2024 |
| End Date | 14-02-2024 |
| Event Time | 08:00 AM |
| Location | UCI-330 |
| Cost (UGX) | 0 |
| CPD Points | 3 |